Medicine Information Article:

Marketing Authorisation - Medicinal Products

Marketing Authorisation: Medicinal Products The case of R (on the application of Merck Sharp and Dohme Ltd) v Licensing Authority [2005], concerned the application for marketing authorisation for a generic product which was based on Product C (see below).

The claimant had marketing authorisations for three medicinal products used in the treatment of osteoporosis and three generic companies sought marketing authorisation for Product C.

Product A - was authorised by the European Community in 1993;

Product B - was authorised in 2000

Product C - was a generic product based on Product B (a copy of Product B).

When a company applies for marketing authorisation for a product, it is a requirement under the European Parliament and Council Directive (EC) 2001/83 (the "Directive"), to supply a full set of data in order to show the safety and efficacy of the product.

There are instances under the Directive when an applicant can simply rely on data submitted in respect of a previously authorised product. For instance, the applicant could refer to data already submitted in respect of a product with marketing authorisation, where the applicant is seeking authorisation for a product 'essentially similar' to a product holding a marketing authorisation for ten years (as per the United Kingdom and pursuant to art 10(i)(a)(iii) of the Directive).

In seeking marketing authorisation for Product C, the generic companies relied on data submitted in relation to Product A and Product B. However, although Product A and Product B contained the same active ingredient, they were not 'essentially similar' within the meaning of the Directive. This meant that they differed in respect of their posology (the schedule of dosage). The defendant accepted that the generic companies did not have to provide any further data but the claimant argued that such an approach was unlawful and in breach of the Directive. The claimant made a reference to the European Court of Justice ("Court of Justice").

The claimant contended that the issue was as yet unresolved by the rules laid down in previous decisions of the ECJ. In particular, it was argued, that there had been no cases where a difference in posology had been the subject of a decision.

The application was dismissed. The ECJ held that:

The principles laid down by the ECJ in earlier decisions were clearly applicable in this case and there was no uncertainty;

Although it was true that a change in posology had not previously been the subject of a decision, it was for the ECJ to interpret the EC Treaty and the relevant principles by which it was to be interpreted, and for the domestic court to apply those principles to the particular case.No new principles arose in the instant case.

If you require further information contact us.

Email: enquiries@rtcoopers.com

© RT COOPERS, 2005. This Briefing Note does not provide a comprehensive or complete statement of the law relating to the issues discussed nor does it constitute legal advice. It is intended only to highlight general issues. Specialist legal advice should always be sought in relation to particular circumstances.

Rosanna Cooper is a partner in RT Coopers Solicitors a full service law firm in London. The firm specialises in patents, trade marks, copyright, designs, technology transfer, biotechnology and pharmaceutical law. The firm has a flexible approach to fees and provides the highest quality legal advice.

Contact us at enquiries@rtcoopers.com. visit our website at http://www.rtcoopers.com

Raw Food For Better Health

A Good Raw Diet for Your Health - These days, we're seeing more and more instances of a variety of autoimmune disorders. Diseases like MS, lupus, rheumatoid arthritis, and a host of others seem to be on the rise. Some say that it's merely due to better diagnostic tools; and others say that it's environmental factors: pollution and the foods we eat that are leading to more people being hit by these maladies.

The Undiscovered Secret For Safer Surgery

Surgery carries undeniable risks with it, no doubt about it. But the dangers of anesthesia, of cutting, drilling, and using lasers is nearly always overshadowed by the overwhelming benefits of the surgery. What if there were a simple, safe way to avoid many of these pitfalls by significantly decreasing the amount of anesthesia a patient needs in order to stay safe anesthetized? Well, there is!

Prescription Drugs Safety Tips

While prescription drugs are very effective treatments for many diseases, it's important to know that no drug, prescription or over-the-counter, is completely safe. While drugs are crucial for controlling or curing illness, many have significant side effects. Learn basic tips to help reduce potential risks and get the most benefit from a drug.

Personalized Medicine - The New Era, Genetic Assessments and You

This article briefly touches upon the fact that personalized medicine has always been a reality for health care practioners. In this day and age, knowledge of the human genome, genetics, DNA, and genetic propensities for illness has opened up a new door regarding personalized medicine and nutrition.

Which Drug is Most Frequently Implicated in Childhood Colitis?

Ulcerative colitis usually does not affect the full thickness of the wall of the large intestine and rarely affects the small intestine. I have seen the info on colitis just would like to see if there is anything else that can be done. The cause of ulcerative colitis is unknown, and currently there is no cure, except through surgical removal of the colon.